Type of Hodgkin's lymphoma-Nodular Lymphocytic predominant Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Type of Hodgkin’s lymphoma-Nodular Lymphocytic predominant Hodgkin’s lymphoma Posts on Medivizor

The effectiveness of chemotherapy and radiotherapy in nodular lymphocyte predominant Hodgkin lymphoma depending on disease stage

The effectiveness of chemotherapy and radiotherapy in nodular lymphocyte predominant Hodgkin lymphoma depending on disease stage

Posted by on Dec 31, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the effectiveness of chemotherapy and radiotherapy (CRT) in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).  This study concluded that combined CRT may be more effective in patients with early-stage NLPHL, particularly in older patients.  Some background...

Read More

Evaluating long-term outcomes for patients with nodular lymphocyte-predominant Hodgkin lymphoma

Posted by on Nov 29, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the long-term outcomes of first-line treatment in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). The authors concluded that survival among these patients was similar to that of the general population. Some background NLPHL is a rare type of Hodgkin lymphoma. When diagnosed, most...

Read More

Evaluating the long-term outcomes of low-dose radiation therapy for early-stage nodular lymphocyte-predominant Hodgkin lymphoma

Posted by on Jun 5, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness of radiation, chemotherapy, or both for the treatment of early-stage nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL). This study concluded that long-term outcomes were favorable across all treatment approaches. Some background NLPHL is a rare subtype of non-Hodgkin's lymphoma....

Read More

Optimal treatment for relapsed and unresponsive nodular lymphocyte-predominant Hodgkin lymphoma

Posted by on Apr 18, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate treatments and outcomes for patients with relapsed or unresponsive nodular lymphocyte-predominant Hodgkin lymphoma. This study concluded that these patients have a good overall prognosis and treatments should be chosen individually. Some background Radiotherapy (RT), chemotherapy (CT) and rituximab...

Read More